SP1-JTI

Be The Cure’ (BTCURE), is an IMI* (http://www.imi.europa.eu/) funded research project which aims to develop new therapies against rheumatoid arthritis. With a total budget of EUR 35 million and 37 partners from all over Europe, it is hoped that by combining academic and industrial resources, basic understanding of disease processes and therapeutic development will be enhanced.

U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) is a research project using information and samples from adults and children to learn more about different types of asthma to ensure better diagnosis and treatment for each person.